All News

If the trends currently in motion continue, you will see the beginning of accountable care organizations in 2012, with increasing numbers of them year by year, unless there is a repeal of the shared savings portion of the Affordable Care Act or the final rule restricts the potential savings that can be obtained by any ACO.

Early experience indicates laser photoselective vaporization prostatectomy using the latest generation of a 532-nm lithium triborate laser is a safe, efficacious, and efficient treatment for lower urinary tract symptoms secondary to BPH.

Men with clinically localized prostate cancer who undergo radical retropubic prostatectomy with bilateral pelvic lymph node dissection show a higher than expected incidence of lymph node metastases, but men with nodal involvement have excellent 10-year clinical recurrence-free survival.

No fully accepted mechanism of action has been accepted to explain the unusual dossier that PDE-5 inhibitors exhibit in male LUTS.

The phosphodiesterase type-5 inhibitor tadalafil (Cialis) significantly improves erectile function as well as symptoms of BPH/lower urinary tract symptoms in men with both ED and BPH.

Even considering the weight of many unknown variables such as the costs of operating room nursing and equipment replacement, it appears that costs for photoselective vaprization of the prostate (PVP) for BPH are substantially less than those seen with transurethral resection of the prostate (TURP).

Active surveillance may be a viable short-term treatment option in select patients with small renal masses, say researchers from Fox Chase Cancer Center, Philadelphia.

Ten-year data from an international registry-based multicenter study showed that 83% of patients with localized prostate cancer had no biopsy evidence of disease after treatment with high-intensity focused ultrasound (HIFU).

In men undergoing transrectal ultrasound-guided prostate biopsy (TRUSP), targeted antimicrobial prophylaxis based on findings from rectal swab cultures significantly reduces the incidence of infectious complications and has implications for decreasing the overall cost of care, according to data reported by researchers from Northwestern University, Chicago.

Results from a retrospective review reveal that microsurgical subinguinal varicocelectomy increases serum testosterone levels in men with clinically palpable varicoceles, regardless of varicocele grade.

Men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) can be do-it-yourselfers when it comes to treating the myofascial component of their pain. And that may mean that the men with a phenotype of muscle tenderness?which may be 60% of CP/CPPS patients?could get significant relief and save money.

A new technique for meshless cystocele repair could avoid the shortcomings seen with traditional mesh placement, say researchers from the UCLA School of Medicine.

The 5-alpha-reductase inhibitor dutasteride (Avodart) is associated with markedly lower BPH-related complication rates than the alpha-blocker tamsulosin (Flomax), according to a post hoc analysis of two large clinical trials of these agents presented yesterday.

The selective beta3-adrenoceptor agonist mirabegron effectively improves symptoms of overactive bladder and is very safe and well tolerated, according to results of a North American phase III study presented yesterday.

Urology Times Contributing Editor Mac Overmyer was among the honorees in the 2011 AUA Excellence in Urology Health Reporting Awards presented yesterday.

The recurrence rate following thermal ablation of renal cortical tumors is 6%. About half of recurrences can be managed successfully with salvage ablative procedures, but 20% require extirpative surgery, according to retrospective findings obtained from databases from 10 U.S. centers.

There appears to be a substantial difference between what patient expectation of recovery of erectile function following radical prostatectomy and what they actually experience.

Men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) are associated with a higher rate of arterial stiffness and vascular endothelial dysfunction than those without the condition, say researchers from Cleveland Clinic.

Among men treated with curative radiation therapy and neoadjuvant, adjuvant, or concurrent ADT, about one-fourth fail to achieve or maintain true castrate levels of testosterone suppression, according to a study from the University of British Columbia, Vancouver.

Patient-reported outcomes after urethral reconstruction reflected improvement in symptomatic and quality of life parameters consistent with objective urodynamic changes, data from a single-center clinical study showed.

Blood loss and transfusions after radical cystectomy for bladder cancer decline significantly with robot-assisted versus open surgery, a review of medical records showed.

The average cost of a laparoscopic partial nephrectomy is nearly $1,500 higher with robot-assisted versus hand-assisted procedures, a retrospective comparative chart review presented yesterday showed.

A study comparing postoperative pain between robot-assisted laparoscopic radical prostatectomy (RALP) and laparoscopic radical prostatectomy (LRP) appears to favor the robotic technique.

In men with high-grade prostate cancer, outcomes after radical prostatectomy are generally poorest for those with a low preoperative PSA (<2.5 ng/mL), according to a results of a study investigating disease-specific outcomes.

While Agent Orange, an herbicide used during the Vietnam War, has been previously linked to a variety of types of cancers in Vietnam veterans, new data from the Veterans Affairs Medical Center in Shreveport, LA, indicates that there may be a connection between veterans? in-country exposure and subsequent development of renal cancer.

BK Medical is showcasing what it?s calling the industry?s first complete ultrasound imaging solution for robot-assisted surgery at this week?s AUA annual meeting.

Results of a retrospective study investigating men with clinically localized prostate cancer who underwent radical retropubic prostatectomy with bilateral pelvic lymph node dissection (PLND) show a higher than expected incidence of LN metastases, but men with nodal involvement had excellent 10-year clinical recurrence-free survival.